Stock Price
44.13
Daily Change
-0.21 -0.47%
Monthly
2.63%
Yearly
-57.03%
Q4 Forecast
43.34

EPS Reference Time Actual Consensus Previous
2026-10-28 FY2026Q3 AM 0.73 0.84 0.75
2026-07-29 FY2026Q2 AM 0.86 0.83 0.75
2026-04-22 FY2026Q1 AM 0.80 0.79 0.75
2026-02-04 FY2025Q4 AM 0.80 0.78 0.70
2025-10-22 FY2025Q3 AM 0.75 0.72 0.63



Peers Price Chg Day Year Date
Abbott 108.71 0.19 0.18% -16.75% Nov/16
AtriCure 56.84 0.86 1.54% 72.77% Nov/13
Baxter International 25.77 -0.04 -0.15% 39.52% Nov/16
Becton, Dickinson and Co. 217.42 -0.61 -0.28% 12.63% Nov/16
Boston Scientific 44.13 -0.21 -0.47% -57.03% Nov/16
CONMED 50.59 0.11 0.22% 20.34% Nov/13
Cooper Companies 62.75 0.10 0.16% -13.00% Nov/16
Danaher 231.92 -1.10 -0.47% 4.84% Nov/16
Dexcom 82.27 -1.06 -1.27% 40.66% Nov/16
Edwards Lifesciences 107.10 -0.05 -0.05% 26.39% Nov/16

Indexes Price Day Year Date
US Index 500 7479 -82.70 -1.09% 12.09% Nov/16

Boston Scientific traded at $44.23 this Monday November 16th, decreasing $0.11 or 0.25 percent since the previous trading session. Looking back, over the last four weeks, Boston Scientific lost 2.86 percent. Over the last 12 months, its price fell by 56.93 percent. Looking ahead, we forecast Boston Scientific to be priced at 43.34 by the end of this quarter and at 40.48 in one year, according to Trading Economics global macro models projections and analysts expectations.

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by businesses such Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. It operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy and Urology and Pelvic Health businesses. Rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.



News Stream
Boston Scientific Stock Price Hits 26-month Low
Boston Scientific shares decreased to 60.46 USD, the lowest since January 2024. Over the past 4 weeks, Boston Scientific lost 12.91%, and in the last 12 months, it decreased 35.29%.
2026-04-21
Boston Scientific Stock Price Hits 25-month Low
Boston Scientific shares decreased to 64.21 USD, the lowest since February 2024. Over the past 4 weeks, Boston Scientific lost 14.65%, and in the last 12 months, it decreased 34.53%.
2026-03-30
Boston Scientific Stock Price Hits 18-month Low
Boston Scientific shares decreased to 72.63 USD, the lowest since August 2024. Over the past 4 weeks, Boston Scientific lost 3.03%, and in the last 12 months, it decreased 29.34%.
2026-03-04